![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
96-week update: change in weight and BMI associated with switching to bictegravir/emtricitabine/tenofovir alafenamide vs. a dolutegravir-based regimen among virologically suppressed adults living with HIV
|
|
|
IAS 2023 july 25
from Jules: 41% were on a TDF regimen before switching so I think switching off TDF automatically can lead to weigh gain making these results most un-interpretable !
"Referral to services that provide counseling on nutrition, exercise and pharmacotherapy for weight loss may be be a valuable intervention", in the Conclusion may be the best advise ! Jules
![0729231](../images/072923/072923-7/0729231.gif)
![0729232](../images/072923/072923-7/0729232.gif)
![0729233](../images/072923/072923-7/0729233.gif)
![0729234](../images/072923/072923-7/0729234.gif)
![0729235](../images/072923/072923-7/0729235.gif)
![0729236](../images/072923/072923-7/0729236.gif)
![0729237](../images/072923/072923-7/0729237.gif)
![0729238](../images/072923/072923-7/0729238.gif)
![0729239](../images/072923/072923-7/0729239.gif)
![07292310](../images/072923/072923-7/07292310.gif)
![07292311](../images/072923/072923-7/07292311.gif)
![07292312](../images/072923/072923-7/07292312.gif)
![07292313](../images/072923/072923-7/07292313.gif)
![07292314](../images/072923/072923-7/07292314.gif)
![07292315](../images/072923/072923-7/07292315.gif)
![07292316](../images/072923/072923-7/07292316.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|